Skip to Main Content

Paper Details

Phase I-II Trial of Early Azacitidine after Matched Unrelated Donor Hematopoietic Cell Transplantation.
Transplant Cell Ther
0
2023
AZA, Azacitidine, GVHD, Graft-versus-host disease, Hematopoietic Cell Transplantation, aGVHD, acute GVHD, azacitidine, cGVHD, chronic GVHD, hematopoietic cell, patients, relapse
Author NameAffiliation
Ravi VijWashington University School of Medicine
Peter WesterveltWashington University School of Medicine
Matthew J WalterWashington University School of Medicine
John F DiPersioWashington University School of Medicine
  • 1 - 4

Datasets

Release 1.2